Found: 60
Select item for more details and to access through your institution.
Oncolytic virotherapy as emerging immunotherapeutic modality: potential of parvovirus H-1.
- Published in:
- Frontiers in Oncology, 2014, v. 4, p. 1, doi. 10.3389/fonc.2014.00092
- By:
- Publication type:
- Article
Parvovirus interference with intracellular signalling: mechanism of PKCη activation in MVM-infected A9 fibroblasts.
- Published in:
- Cellular Microbiology, 2008, v. 10, n. 3, p. 755, doi. 10.1111/j.1462-5822.2007.01082.x
- By:
- Publication type:
- Article
Synergistic combination of valproic acid and oncolytic parvovirus H-1 PV as a potential therapy against cervical and pancreatic carcinomas.
- Published in:
- EMBO Molecular Medicine, 2013, v. 5, n. 10, p. 1537, doi. 10.1002/emmm.201302796
- By:
- Publication type:
- Article
UV-ENHANCED REACTIVATION OF MINUTE-VIRUS-OF-MICE: STIMULATION OF A LATE STEP IN THE VIRAL LIFE CYCLE.
- Published in:
- Photochemistry & Photobiology, 1981, v. 33, n. 6, p. 845, doi. 10.1111/j.1751-1097.1981.tb05502.x
- By:
- Publication type:
- Article
A non-controlled, single arm, open label, phase II study of intravenous and intratumoral administration of ParvOryx in patients with metastatic, inoperable pancreatic cancer: ParvOryx02 protocol.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Dose-dependent regression of HeLa cell-derived tumours in SCID mice after parvovirus H-1 infection.
- Published in:
- International Journal of Cancer, 1998, v. 75, n. 4, p. 584, doi. 10.1002/(SICI)1097-0215(19980209)75:4<584::AID-IJC15>3.0.CO;2-9
- By:
- Publication type:
- Article
A new hexapeptide from the leader peptide of rMnSOD enters cells through the oestrogen receptor to deliver therapeutic molecules.
- Published in:
- Scientific Reports, 2016, p. 18691, doi. 10.1038/srep18691
- By:
- Publication type:
- Article
TLR-9 Contributes to the Antiviral Innate Immune Sensing of Rodent Parvoviruses MVMp and H-1PV by Normal Human Immune Cells.
- Published in:
- PLoS ONE, 2013, v. 8, n. 1, p. 1, doi. 10.1371/journal.pone.0055086
- By:
- Publication type:
- Article
Activation of a Helper and Not Regulatory Human CD4+ T Cell Response by Oncolytic H-1 Parvovirus.
- Published in:
- PLoS ONE, 2012, v. 7, n. 2, p. 1, doi. 10.1371/journal.pone.0032197
- By:
- Publication type:
- Article
Antitumoral activity of parvovirus-mediated IL-2 and MCP-3/CCL7 delivery into human pancreatic cancer: implication of leucocyte recruitment.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 11, p. 2113, doi. 10.1007/s00262-012-1279-4
- By:
- Publication type:
- Article
Immune Conversion of Tumor Microenvironment by Oncolytic Viruses: The Protoparvovirus H-1PV Case Study.
- Published in:
- Frontiers in Immunology, 2019, p. 1, doi. 10.3389/fimmu.2019.01848
- By:
- Publication type:
- Article
H-1 Parvovirus-Induced Oncolysis and Tumor Microenvironment Immune Modulation in a Novel Heterotypic Spheroid Model of Cutaneous T-Cell Lymphoma.
- Published in:
- Cancers, 2024, v. 16, n. 15, p. 2711, doi. 10.3390/cancers16152711
- By:
- Publication type:
- Article
Parvovirus-Based Combinatorial Immunotherapy: A Reinforced Therapeutic Strategy against Poor-Prognosis Solid Cancers.
- Published in:
- Cancers, 2021, v. 13, n. 2, p. 342, doi. 10.3390/cancers13020342
- By:
- Publication type:
- Article
Emerging role of Natural killer cells in oncolytic virotherapy.
- Published in:
- ImmunoTargets & Therapy, 2015, v. 4, p. 65, doi. 10.2147/ITT.S55549
- By:
- Publication type:
- Article
Regression of advanced rat and human gliomas by local or systemic treatment with oncolytic parvovirus H-1 in rat models.
- Published in:
- Neuro-Oncology, 2010, v. 12, n. 8, p. 804, doi. 10.1093/neuonc/noq023
- By:
- Publication type:
- Article
Vesicular Egress of Non-Enveloped Lytic Parvoviruses Depends on Gelsolin Functioning.
- Published in:
- PLoS Pathogens, 2008, v. 4, n. 8, p. 1, doi. 10.1371/journal.ppat.1000126
- By:
- Publication type:
- Article
Oncolytic parvovirus H1 induces release of heat-shock protein HSP72 in susceptible human tumor cells but may not affect primary immune cells.
- Published in:
- Cancer Gene Therapy, 2003, v. 10, n. 6, p. 477, doi. 10.1038/sj.cgt.7700591
- By:
- Publication type:
- Article
Suppression of metastatic hemangiosarcoma by a parvovirus MVMp vector transducing the IP-10 chemokine into immunocompetent mice.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 5, p. 432, doi. 10.1038/sj.cgt.7700457
- By:
- Publication type:
- Article
Potentiation of a recombinant oncolytic parvovirus by expression of Apoptin.
- Published in:
- Cancer Gene Therapy, 2001, v. 8, n. 12, p. 958, doi. 10.1038/sj.cgt.7700392
- By:
- Publication type:
- Article
Effective infection, apoptotic cell killing and gene transfer of human hepatoma cells but not primary hepatocytes by parvovirus H1 and derived vectors.
- Published in:
- Cancer Gene Therapy, 2001, v. 8, n. 3, p. 158, doi. 10.1038/sj.cgt.7700288
- By:
- Publication type:
- Article
The Complex Role of Infectious Agents in Human Cutaneous T-Cell Lymphoma Pathogenesis: From Candidate Etiological Factors to Potential Therapeutics.
- Published in:
- Pathogens, 2024, v. 13, n. 3, p. 184, doi. 10.3390/pathogens13030184
- By:
- Publication type:
- Article
Oncolytic Rodent Protoparvoviruses Evade a TLR- and RLR-Independent Antiviral Response in Transformed Cells.
- Published in:
- Pathogens, 2023, v. 12, n. 4, p. 607, doi. 10.3390/pathogens12040607
- By:
- Publication type:
- Article
Generation and Validation of Monoclonal Antibodies Suitable for Detecting and Monitoring Parvovirus Infections.
- Published in:
- Pathogens, 2022, v. 11, n. 2, p. 208, doi. 10.3390/pathogens11020208
- By:
- Publication type:
- Article
The Oncolytic Virotherapy Era in Cancer Management: Prospects of Applying H-1 Parvovirus to Treat Blood and Solid Cancers.
- Published in:
- Frontiers in Oncology, 2017, v. 7, p. 1, doi. 10.3389/fonc.2017.00093
- By:
- Publication type:
- Article
Biophysical and biochemical characterization of a liposarcoma-derived recombinant MnSOD protein acting as an anticancer agent.
- Published in:
- International Journal of Cancer, 2008, v. 123, n. 11, p. 2684, doi. 10.1002/ijc.23791
- By:
- Publication type:
- Article
Arming parvoviruses with CpG motifs to improve their oncosuppressive capacity.
- Published in:
- International Journal of Cancer, 2008, v. 122, n. 12, p. 2880, doi. 10.1002/ijc.23472
- By:
- Publication type:
- Article
MCP-3 (CCL7) delivered by parvovirus MVMp reduces tumorigenicity of mouse melanoma cells through activation of T lymphocytes and NK cells.
- Published in:
- International Journal of Cancer, 2007, v. 120, n. 6, p. 1364, doi. 10.1002/ijc.22421
- By:
- Publication type:
- Article
Tumor suppressive activity of a variant isoform of manganese superoxide dismutase released by a human liposarcoma cell line.
- Published in:
- International Journal of Cancer, 2006, v. 119, n. 4, p. 932, doi. 10.1002/ijc.21904
- By:
- Publication type:
- Article
Carrier cell-mediated delivery of oncolytic parvoviruses for targeting metastases.
- Published in:
- International Journal of Cancer, 2004, v. 109, n. 5, p. 742, doi. 10.1002/ijc.20013
- By:
- Publication type:
- Article
Parvovirus H-1 infection of human glioma cells leads to complete viral replication and efficient cell killing.
- Published in:
- International Journal of Cancer, 2004, v. 109, n. 1, p. 76, doi. 10.1002/ijc.11626
- By:
- Publication type:
- Article
Immune System Stimulation by Oncolytic Rodent Protoparvoviruses.
- Published in:
- Viruses (1999-4915), 2019, v. 11, n. 5, p. 415, doi. 10.3390/v11050415
- By:
- Publication type:
- Article
Preclinical Testing of an Oncolytic Parvovirus in Ewing Sarcoma: Protoparvovirus H-1 Induces Apoptosis and Lytic Infection In Vitro but Fails to Improve Survival In Vivo.
- Published in:
- Viruses (1999-4915), 2018, v. 10, n. 6, p. 302, doi. 10.3390/v10060302
- By:
- Publication type:
- Article
Mutations in the Non-Structural Protein-Coding Sequence of Protoparvovirus H-1PV Enhance the Fitness of the Virus and Show Key Benefits Regarding the Transduction Efficiency of Derived Vectors.
- Published in:
- Viruses (1999-4915), 2018, v. 10, n. 4, p. 150, doi. 10.3390/v10040150
- By:
- Publication type:
- Article
Immunotherapeutic Potential of Oncolytic H-1 Parvovirus: Hints of Glioblastoma Microenvironment Conversion towards Immunogenicity.
- Published in:
- Viruses (1999-4915), 2017, v. 9, n. 12, p. 382, doi. 10.3390/v9120382
- By:
- Publication type:
- Article
Preclinical Testing of an Oncolytic Parvovirus: Standard Protoparvovirus H-1PV Efficiently Induces Osteosarcoma Cell Lysis In Vitro.
- Published in:
- Viruses (1999-4915), 2017, v. 9, n. 10, p. 301, doi. 10.3390/v9100301
- By:
- Publication type:
- Article
Overcoming Barriers in Oncolytic Virotherapy with HDAC Inhibitors and Immune Checkpoint Blockade.
- Published in:
- Viruses (1999-4915), 2016, v. 8, n. 4, p. 9, doi. 10.3390/v8010009
- By:
- Publication type:
- Article
Overcoming Barriers in Oncolytic Virotherapy with HDAC Inhibitors and Immune Checkpoint Blockade.
- Published in:
- Viruses (1999-4915), 2016, v. 8, n. 1, p. 9, doi. 10.3390/v8010009
- By:
- Publication type:
- Article
PKCη/Rdx-driven Phosphorylation of PDK1: A Novel Mechanism Promoting Cancer Cell Survival and Permissiveness for Parvovirus-induced Lysis.
- Published in:
- PLoS Pathogens, 2015, v. 11, n. 3, p. 1, doi. 10.1371/journal.ppat.1004703
- By:
- Publication type:
- Article
Vesicular Transport of Progeny Parvovirus Particles through ER and Golgi Regulates Maturation and Cytolysis.
- Published in:
- PLoS Pathogens, 2013, v. 9, n. 9, p. 1, doi. 10.1371/journal.ppat.1003605
- By:
- Publication type:
- Article
Oncogenic transformation-dependent expression of a transcription factor NF-Y subunit.
- Published in:
- Molecular Carcinogenesis, 1999, v. 24, n. 4, p. 294, doi. 10.1002/(SICI)1098-2744(199904)24:4<294::AID-MC7>3.0.CO;2-Q
- By:
- Publication type:
- Article
Identification of a Transformation-Sensitive Nuclear Protein From Normal Human Fibroblasts That Specifically Interacts With Minute Virus of Mice DNA and Correlates With Cell Resistance to the Parvovirus.
- Published in:
- Molecular Carcinogenesis, 1989, v. 2, n. 5, p. 245, doi. 10.1002/mc.2940020504
- By:
- Publication type:
- Article
Rational Combination of Parvovirus H1 With CTLA-4 and PD-1 Checkpoint Inhibitors Dampens the Tumor Induced Immune Silencing.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00425
- By:
- Publication type:
- Article
Oncolytic effects of parvovirus H-1 in medulloblastoma are associated with repression of master regulators of early neurogenesis.
- Published in:
- International Journal of Cancer, 2014, v. 134, n. 3, p. 703, doi. 10.1002/ijc.28386
- By:
- Publication type:
- Article
Enhancement of NK cell antitumor responses using an oncolytic parvovirus.
- Published in:
- International Journal of Cancer, 2011, v. 128, n. 4, p. 908, doi. 10.1002/ijc.25415
- By:
- Publication type:
- Article
Parvovirus H1 selectively induces cytotoxic effects on human neuroblastoma cells.
- Published in:
- International Journal of Cancer, 2010, v. 127, n. 5, p. 1230, doi. 10.1002/ijc.25168
- By:
- Publication type:
- Article
SMAD4: a predictive marker of PDAC cell permissiveness for oncolytic infection with parvovirus H-1PV.
- Published in:
- International Journal of Cancer, 2010, v. 126, n. 12, p. 2914, doi. 10.1002/ijc.24992
- By:
- Publication type:
- Article
Humoral immune responses against minute virus of mice vectors.
- Published in:
- Journal of Gene Medicine, 2006, v. 8, n. 9, p. 1141, doi. 10.1002/jgm.940
- By:
- Publication type:
- Article
Vectors based on autonomous parvoviruses: novel tools to treat cancer?
- Published in:
- Journal of Gene Medicine, 2004, v. 6, p. S193, doi. 10.1002/jgm.502
- By:
- Publication type:
- Article
Oncolytic murine autonomous parvovirus, a candidate vector for glioma gene therapy, is innocuous to normal and immunocompetent mouse glial cells.
- Published in:
- Cell & Tissue Research, 2006, v. 325, n. 3, p. 423, doi. 10.1007/s00441-006-0199-z
- By:
- Publication type:
- Article
Oncolytic Rat Parvovirus H-1PV, a Candidate for the Treatment of Human Lymphoma: In Vitro and In Vivo Studies.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 7, p. 1164, doi. 10.1038/mt.2009.78
- By:
- Publication type:
- Article